Literature DB >> 2852674

Application of immunoassay of encephalomyocarditis virus in cell culture with enzyme-labeled virus-specific monoclonal antibodies for rapid detection of virus, neutralizing antibodies, and interferon.

F Vlaspolder1, T Harmsen, D van Veenendaal, C A Kraaijeveld, H Snippe.   

Abstract

Encephalomyocarditis virus (EMCV)-specific monoclonal antibody UM 21.1 labeled with horseradish peroxidase was used to detect EMCV in L-cell monolayers. This direct enzyme immunoassay of EMCV, performed in wells of 96-well plates, could be applied for various purposes, such as early detection of virus multiplication, determination of 50% tissue culture infective doses, and rapid titration of interferon and EMCV-neutralizing antibodies. Multiplication of EMCV is indicated by a rapid increase of the absorbance values measured against EMCV-infected L cells starting as early as 4.5 h after virus inoculation. The early rise of absorbance (i.e., virus multiplication) is inhibited by interferon, allowing its rapid titration. Preincubation of the virus inoculum with neutralizing antibodies also yielded decreased absorbance values. With the latter enzyme immunoassay for neutralizing antibodies, performed after an infection period of 8 h, antibody titers measured were comparable to those obtained with a conventional plaque reduction test. We assume that similar assays could be developed for other picornaviruses (e.g., polioviruses).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2852674      PMCID: PMC266953          DOI: 10.1128/jcm.26.12.2593-2597.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Prophylaxis and therapy of virulent encephalomyocarditis virus infection in mice by monoclonal antibodies. Brief report.

Authors:  F Vlaspolder; C A Kraaijeveld; R van Buuren; M Harmsen; B J Benaissa-Trouw; H Snippe
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

2.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

3.  Hapten-specific B cell repertoire probed by hybridoma technology: selection and characterization of representative clonotypes from the antibody-forming cell pool.

Authors:  A G Bloor; Y Jou; C Hoeplinger; J E Gartner; G L Mayers; R B Bankert
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

Review 4.  The biological origin of antibody diversity.

Authors:  A R Williamson
Journal:  Annu Rev Biochem       Date:  1976       Impact factor: 23.643

5.  Monoclonal antibodies for diagnosis of infectious diseases in humans.

Authors:  R C Nowinski; M R Tam; L C Goldstein; L Stong; C C Kuo; L Corey; W E Stamm; H H Handsfield; J S Knapp; K K Holmes
Journal:  Science       Date:  1983-02-11       Impact factor: 47.728

6.  Cellular localization of five structural proteins of Sendai virus studied with peroxidase-labelled Fab fragments of monoclonal antibodies.

Authors:  K Kristensson; C Orvell
Journal:  J Gen Virol       Date:  1983-08       Impact factor: 3.891

Review 7.  Monoclonal antibodies: a powerful new tool in biology and medicine.

Authors:  D E Yelton; M D Scharff
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

8.  Immunization of mice with live attenuated encephalomyocarditis virus: local immunity and survival.

Authors:  W J Bogaerts
Journal:  Infect Immun       Date:  1973-10       Impact factor: 3.441

9.  Rapid immunoperoxidase assay for detection of respiratory syncytial virus in nasopharyngeal secretions.

Authors:  R Cevenini; M Donati; A Moroni; L Franchi; F Rumpianesi
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

10.  Monoclonal antibodies for rapid, strain-specific identification of influenza virus isolates.

Authors:  N J Schmidt; M Ota; D Gallo; V L Fox
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

View more
  2 in total

1.  Blocking by anti-idiotypic antibodies of monoclonal antibody mediated protection in mice against encephalomyocarditis virus induced diabetes and lethal disease.

Authors:  F Vlaspolder; T A Oosterlaken; M Harmsen; P W van Dijk; H Kievit; C A Kraaijeveld; H Snippe
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  Neutralization enzyme immunoassay for influenza virus.

Authors:  C A Benne; M Harmsen; J C De Jong; C A Kraaijeveld
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.